# US 5,707,668 A · Process of preparing a spread > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 5,707,668 A - Document ID: US5707668A - Status: Granted - Kind: A - Application number: 08/776,935 - Filed: 1997-02-12 - Granted: 1998-01-13 - Earliest claimed: 1994-09-16 - Assignees: Novo Nordisk A/S - Inventors: Lars Peter Andersen - Web page: https://patentgrep.com/patent/US5707668A ## CPC - A23D 7/0056: {Spread compositions} - A23D 7/02: characterised by the production or working-up {(kneading, forming A01J21/00)} - A23D: EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS (preservation thereof A23B20/00; production, refinement or preservation of animal or vegetable fats or oils C11B, C11C) ## Abstract The present invention relates to a process of preparing a spread and the use of an enzyme in the production of a spread. The process of preparing a spread includes the following steps: a) the aqueous phase, which includes protein, is treated with an enzyme capable of enhancing the viscosity of the aqueous phase, b) the pH-value is adjusted to 4.8 to 6.0, c) the aqueous phase or emulsion is heated to between 60.degree. C. and 100.degree. C. for a period of time, d) the aqueous phase or the emulsion is tempered to a temperature between 30.degree. C. and 50.degree. C., e) the tempered aqueous phase is mixed with the fat phase and tempered to between 30.degree. C. and 50.degree. C. until an emulsion is formed, f) the emulsion is crystallized to form a spread. The steps in the process may be performed in the sequence steps a), b), c), d) e), f) or a), b), d), e), c), d), f). ## Claims ### Claim 1 A process of preparing a spread, wherein a water phase comprising protein(s) is mixed with a fat phase, comprising the following steps: a) treating the aqueous phase comprising protein(s) with an enzyme capable of enhancing the viscosity of the aqueous phase, b) adjusting the pH-value to a value in the range from 4.8 to 6.0, c) heating the aqueous phase or the emulsion to a temperature between 60.degree. C. and 100.degree. C. for a period of time, d) tempering the aqueous phase or the emulsion to a temperature between 30.degree. C. and 50.degree. C., e) mixing the tempered aqueous phase with the fat phase tempered to a temperature between 30.degree. C. and 50.degree. C. until an emulsion is formed, f) crystallizing the emulsion to form a spread, characterized in that said process is performed in step sequence a)-b)-c)-d)-e)-f) or a)-b)-d)-e)-c)-d)-f). ### Claim 2 (depends on 1) The process according to claim 1, wherein the aqueous phase in step a) is treated with enzyme under conditions comprising a pH-value in the range of 5.5 to 7.0, and at a temperature of between 20.degree. C. and 60.degree. C. ### Claim 3 (depends on 1) The process according to claim 1, wherein the pH-value in step b) is adjusted to a value in the range from 5.0 to 5.2. ### Claim 4 (depends on 1) The process according to claim 1, wherein the aqueous phase or the emulsion in step c) is heated to a temperature between 70.degree. C. and 90.degree. C. for a period of between 1 minute and 10 hours. ### Claim 5 (depends on 1) The process according claim 1, wherein the crystallisation in step f) is performed using a tube chiller or a Kombinator. ### Claim 6 (depends on 1) The process according to claim 1, wherein the protein is present in the aqueous phase in an amount of between 0.01-6.0 wt. % of the final spread product. ### Claim 7 (depends on 6) The process according to claim 6, wherein the protein is skim milk powder from milk, caseinate, whey protein from milk, soy protein, pea protein, or mixtures thereof. ### Claim 8 (depends on 1) The process according to claim 1, wherein the enzyme used for treating the aqueous phase is transglutaminase of mammalian origin, or variants thereof. ### Claim 9 (depends on 8) The process according to claim 8, wherein said mammalian transglutaminase is of human or bovine origin. ### Claim 10 (depends on 9) The process according to claim 9, wherein the transglutaminase is Factor XIIIa of human origin. ### Claim 11 (depends on 8) The process according to claim 8, wherein the purified enzyme protein for treating the aqueous phase is present in a concentration of 0.01 wt. % to 1.0 wt. % calculated on the basis of the protein content in the spread. ### Claim 12 (depends on 1) The process according to claim 1, wherein the enzyme used for treating the aqueous phase is transglutaminase of microbial origin, or variants thereof. ### Claim 13 (depends on 12) The process according to claim 12, wherein said microbial enzyme is a transglutaminase of bacterial origin. ### Claim 14 (depends on 13) The process according to claim 13, wherein said bacterial transglutaminase is derived from Streptomyces libani. ### Claim 15 (depends on 1) The process according to claim 1, wherein the enzyme for treating the aqueous phase is the component C, produced by Bacillus licheniformis, or variants thereof. ### Claim 16 (depends on 1) The process according to claim 1, wherein the fat phase constitutes between 10-80 wt. % and the aqueous phase constitutes between 20-90 wt. % of the final spread product. ### Claim 17 (depends on 1) The process according to claim 1, wherein the aqueous phase and/or the fat phase is treated with other conventional additives used in the production of spreads, selected from the group consisting of emulsifying agent, colorants, flavour components, and hydrocolloids in a reduced amount. ### Claim 18 (depends on 1) A spread product produced according to the process of claim 1. ### Claim 19 (depends on 18) The spread product according to claim 18, being a low-fat spread, having a fat content of between 10 and 40 wt. %.